Cara Therapeutics (CARA) Set to Join S&P SmallCap 600

Cara Therapeutics Inc. (NASDAQ: CARA) will replace MTS Systems Corp. (NASDAQ: MTSC) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, April 8. S&P 500 constituent Amphenol Corp. (NYSE: APH) is acquiring MTS Systems in a deal expected to be completed soon pending final closing conditions.

You May Also Be Interested In

• Krystal Biotech to join S&P MidCap 400, Tutor Perini and V2X to join S&P SmallCap 600
• QVC Group bankruptcy court confirms reorganization plan
• Silo Pharma, Inc. (SILO) files for 1.91M share offering by selling stockholders